SOLIQUA
INSULIN GLARGINE AND LIXISENATIDE · by SANOFI-AVENTIS
INSULINS AND ANALOGUES Recombinant human insulin analogue/Glucagon-Like Peptide-1 Receptor Agonists SANOFI-AVENTIS
Composition
PFS Inj: Lixisenatide 33 mcg per 1 ml and Insulin Glargine 100 unit per 1ml, Lixisenatide 50 mcg per 1 ml and Insulin glargine 100 unit per 1ml
Indications & Dosage
Type 2 diabetes mellitus (in combination with metformin): By SC Inj: Adult: (consult product literature)
Contraindications
During episodes of hypoglycemia, hypersensitivity to drug
Precautions
Ace Inhibitors, Beta-blockers, Angiotensin II Receptor Blockers, Sulfonamide Antibodies, MAOIs, Atypical Antipsychotics, Corticosteroid, Danazol, Diuretics, Estrogen, Glucagon, Progestogens, Protease Inhibitors, Thyroid Hormones, Sympathomimetic Agents.